The Expanding Prevalence Of Opioid Overdoses Is Anticipated To Open Up The New Avenue For U.S. Naloxone Market
Naloxone Market |
The U.S. Naloxone Market is estimated to be valued at US$ 1532.55 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Naloxone is an opioid antagonist that is widely used to counter the effects of
opioid overdose. It works by competitively binding to opioid receptors and
reversing the life-threatening depression of the central nervous and
respiratory systems that can occur during an overdose. Naloxone is available in
injectable and nasal spray formulations. Growing cases of opioid abuse and
increasing product availability through community-based programs are major
factors driving the market growth.
Market Dynamics:
A key driver for the growth of U.S. naloxone market is the rising prevalence of
opioid overdose deaths in the country. According to National Institute on Drug
Abuse, over 47,000 Americans died due to opioid overdose in 2019. Another
driver is increasing adoption of community-based naloxone distribution programs
by various government agencies, non-profit organizations, and healthcare
providers. For instance, state departments of health are offering naloxone kits
without a prescription. This is helping to reduce fatalities from opioid
overdoses. In addition, various non-profit organizations such as Operation
Naloxone are providing free naloxone kits across 42 U.S. states to reverse
overdoses in case of emergencies. Such programs play a crucial role in
providing access to naloxone and saving lives.
Comments
Post a Comment